{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:56Z","timestamp":1789519616374,"version":"build-2803163510"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PGPM"],"DOI":"10.2147\/pgpm.s6969","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T07:18:41Z","timestamp":1290583121000},"page":"145","source":"Crossref","is-referenced-by-count":11,"title":["The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes"],"prefix":"10.2147","author":[{"given":"Peter","family":"Light","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,11]]},"container-title":["Pharmacogenomics and Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=8205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:14:00Z","timestamp":1477865640000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/the-molecular-mechanisms-and-pharmacotherapy-of-atp-sensitive-potassiu-peer-reviewed-article-PGPM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/pgpm.s6969","relation":{},"ISSN":["1178-7066"],"issn-type":[{"value":"1178-7066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}